- Home
- CAAP vs HAE Comparison
CAAP vs HAE Comparison
Compare CAAP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- HAE
- Stock Information
- Founded
- CAAP 1998
- HAE 1971
- Country
- CAAP Luxembourg
- HAE United States
- Employees
- CAAP N/A
- HAE N/A
- Industry
- CAAP Aerospace
- HAE Medical/Dental Instruments
- Sector
- CAAP Consumer Discretionary
- HAE Health Care
- Exchange
- CAAP Nasdaq
- HAE Nasdaq
- Market Cap
- CAAP 3.4B
- HAE 3.3B
- IPO Year
- CAAP 2018
- HAE 1991
- Fundamental
- Price
- CAAP $21.46
- HAE $54.56
- Analyst Decision
- CAAP Strong Buy
- HAE Buy
- Analyst Count
- CAAP 2
- HAE 11
- Target Price
- CAAP $24.35
- HAE $86.73
- AVG Volume (30 Days)
- CAAP 126.6K
- HAE 1.3M
- Earning Date
- CAAP 08-20-2025
- HAE 08-07-2025
- Dividend Yield
- CAAP N/A
- HAE N/A
- EPS Growth
- CAAP N/A
- HAE 46.89
- EPS
- CAAP 0.93
- HAE 3.28
- Revenue
- CAAP $1,873,095,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- CAAP $1.18
- HAE N/A
- Revenue Next Year
- CAAP $12.98
- HAE $6.50
- P/E Ratio
- CAAP $23.30
- HAE $16.62
- Revenue Growth
- CAAP 26.88
- HAE 0.91
- 52 Week Low
- CAAP $14.12
- HAE $50.68
- 52 Week High
- CAAP $22.85
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- CAAP 54.86
- HAE 33.12
- Support Level
- CAAP $20.29
- HAE $53.90
- Resistance Level
- CAAP $21.96
- HAE $56.64
- Average True Range (ATR)
- CAAP 0.86
- HAE 1.64
- MACD
- CAAP -0.02
- HAE 0.46
- Stochastic Oscillator
- CAAP 45.70
- HAE 65.10
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.